BRPI0910854A2 - métodos de tratamento - Google Patents

métodos de tratamento

Info

Publication number: BRPI0910854A2
Authority: BR; Brazil
Prior art keywords: treatment methods; treatment; methods
Prior art date: 2008-03-28

Application number

BRPI0910854A

Other languages

English (en)

Portuguese (pt)

Inventor

Fredrick E Hargreave

Giampietro Ventresca

Original Assignee

Glaxosmithkline Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-28

Filing date

2009-03-27

Publication date

2015-10-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41114741&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0910854(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-03-27 Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc

2015-10-06 Publication of BRPI0910854A2 publication Critical patent/BRPI0910854A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5409—IL-5

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Diabetes (AREA)
Tropical Medicine & Parasitology (AREA)
Hematology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Endocrinology (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Nutrition Science (AREA)
Neurology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0910854A 2008-03-28 2009-03-27 métodos de tratamento BRPI0910854A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4036308P	2008-03-28	2008-03-28
PCT/US2009/038509 WO2009120927A2 (en)	2008-03-28	2009-03-27	Methods of treatment

Publications (1)

Publication Number	Publication Date
BRPI0910854A2 true BRPI0910854A2 (pt)	2015-10-06

Family

ID=41114741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0910854A BRPI0910854A2 (pt)	2008-03-28	2009-03-27	métodos de tratamento

Country Status (14)

Country	Link
US (3)	US9834600B2 (2)
EP (1)	EP2274009B1 (2)
JP (4)	JP5917143B2 (2)
KR (1)	KR20100134702A (2)
CN (1)	CN102026660A (2)
AU (1)	AU2009228163B2 (2)
BR (1)	BRPI0910854A2 (2)
CA (1)	CA2719786A1 (2)
EA (1)	EA201071137A1 (2)
ES (1)	ES2441945T3 (2)
IL (1)	IL208354A0 (2)
MX (1)	MX2010010667A (2)
WO (1)	WO2009120927A2 (2)
ZA (1)	ZA201006648B (2)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010521496A (ja)	2007-03-14	2010-06-24	ノップニューロサイエンシーズ、インク．	キラル精製置換ベンゾチアゾールジアミンの合成
JP5917143B2 (ja)	2008-03-28	2016-05-11	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅＬＬＣ	処置方法
US20110190356A1 (en)	2008-08-19	2011-08-04	Knopp Neurosciences Inc.	Compositions and Methods of Using (R)- Pramipexole
WO2012019168A2 (en)	2010-08-06	2012-02-09	Moderna Therapeutics, Inc.	Engineered nucleic acids and methods of use thereof
EP2625189B1 (en)	2010-10-01	2018-06-27	ModernaTX, Inc.	Engineered nucleic acids and methods of use thereof
AU2012236099A1 (en)	2011-03-31	2013-10-03	Moderna Therapeutics, Inc.	Delivery and formulation of engineered nucleic acids
US9464124B2 (en)	2011-09-12	2016-10-11	Moderna Therapeutics, Inc.	Engineered nucleic acids and methods of use thereof
DE19216461T1 (de)	2011-10-03	2021-10-07	Modernatx, Inc.	Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
CA3018046A1 (en)	2011-12-16	2013-06-20	Moderna Therapeutics, Inc.	Modified nucleoside, nucleotide, and nucleic acid compositions
WO2013096816A1 (en)	2011-12-22	2013-06-27	Biogen Idec Ma Inc.	Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
WO2013151665A2 (en)	2012-04-02	2013-10-10	modeRNA Therapeutics	Modified polynucleotides for the production of proteins associated with human disease
US9572897B2 (en)	2012-04-02	2017-02-21	Modernatx, Inc.	Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en)	2012-04-02	2016-03-15	Moderna Therapeutics, Inc.	Modified polynucleotides for the production of nuclear proteins
US9254311B2 (en)	2012-04-02	2016-02-09	Moderna Therapeutics, Inc.	Modified polynucleotides for the production of proteins
PL2922554T3 (pl)	2012-11-26	2022-06-20	Modernatx, Inc.	Na zmodyfikowany na końcach
US9662313B2 (en)	2013-02-28	2017-05-30	Knopp Biosciences Llc	Compositions and methods for treating amyotrophic lateral sclerosis in responders
US8980864B2 (en)	2013-03-15	2015-03-17	Moderna Therapeutics, Inc.	Compositions and methods of altering cholesterol levels
US9468630B2 (en)	2013-07-12	2016-10-18	Knopp Biosciences Llc	Compositions and methods for treating conditions related to increased eosinophils
PL3019167T3 (pl)	2013-07-12	2021-06-14	Knopp Biosciences Llc	Leczenie podwyższonych poziomów eozynofili i/lub bazofili
EP3038467B1 (en)	2013-08-13	2020-07-29	Knopp Biosciences LLC	Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
DK3033081T3 (da)	2013-08-13	2021-05-31	Knopp Biosciences Llc	Sammensætninger og fremgangsmåder til behandling af kronisk urticaria
WO2015048744A2 (en)	2013-09-30	2015-04-02	Moderna Therapeutics, Inc.	Polynucleotides encoding immune modulating polypeptides
EP3052521A1 (en)	2013-10-03	2016-08-10	Moderna Therapeutics, Inc.	Polynucleotides encoding low density lipoprotein receptor
UA122670C2 (uk) *	2014-09-08	2020-12-28	Сефалон, Інк.	Спосіб лікування еозинофільної астми у пацієнта
KR20180037275A (ko)	2015-08-24	2018-04-11	글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드	생물제약 조성물
CN117018188A (zh)	2017-05-26	2023-11-10	葛兰素史密斯克莱知识产权发展有限公司	生物制药组合物和相关方法
WO2022031956A1 (en) *	2020-08-05	2022-02-10	Knopp Biosciences Llc	Use of dexpramipexole for the treatment of moderate to severe asthma
WO2026053108A1 (en) *	2024-09-03	2026-03-12	Glaxosmithkline Intellectual Property (No. 2) Limited	Method of treatment

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8800397D0 (en) *	1988-01-08	1988-02-10	Sandoz Ltd	Improvements in/relating to organic compounds
AU633034B2 (en)	1988-11-03	1993-01-21	Schering Corporation	Method of preventing or reducing eosinophilia
US5096704A (en) *	1988-11-03	1992-03-17	Schering Corporation	Method of treating eosinophilia
US5530101A (en) *	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
EP0533006A1 (en) *	1991-09-18	1993-03-24	F.Hoffmann-La Roche & Co. Aktiengesellschaft	Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
DE69309472T2 (de)	1992-01-23	1997-10-23	Merck Patent Gmbh, 64293 Darmstadt	Fusionsproteine von monomeren und dimeren von antikörperfragmenten
HUT67943A (en)	1992-02-06	1995-05-29	Schering Corp	Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
JPH06141885A (ja)	1992-11-05	1994-05-24	Chemo Sero Therapeut Res Inst	モノクローナル抗体
WO1995014040A1 (en)	1993-11-19	1995-05-26	Baylor College Of Medicine	Monoclonal antibodies specific for human interleukin-5
GB9412230D0 (en)	1994-06-17	1994-08-10	Celltech Ltd	Interleukin-5 specific recombiant antibodies
US7399837B2 (en) *	1995-12-22	2008-07-15	Smithkline Beecham Corporation	Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5693323A (en) *	1994-12-23	1997-12-02	Smithkline Beecham Corporation	Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5783184A (en) *	1994-12-23	1998-07-21	Smithkline Beecham Corporation	Method for treatment and diagnosis of IL-5 mediated disorders
CA2208503C (en)	1994-12-23	2009-12-01	Smithkline Beecham P.L.C.	Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
US6248723B1 (en) *	1997-06-10	2001-06-19	National Jewish Medical And Research Center	Method for treatment of inflammatory disease
DE69838338T2 (de) *	1997-10-22	2008-05-21	Jens Rochester Ponikau	Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
WO2001012646A1 (en)	1999-08-19	2001-02-22	Smithkline Beecham Corporation	Sialoadhesin factor-1 agonist and antagonist antibodies
US20030017169A1 (en) *	2000-12-29	2003-01-23	Sidney Pestka	Controlled release systems for polymers
PT1527100E (pt) *	2002-03-29	2009-08-25	Schering Corp	Anticorpos monoclonais humanos para interleucina-5 e métodos e composições compreendendo os mesmos
US7339507B1 (en) *	2006-09-13	2008-03-04	Jiun-In Guo	Device for video decoding
CN101558081B (zh) *	2006-12-11	2014-08-20	伯拉考成像股份公司	用于诊断和治疗应用的纤维蛋白结合肽缀合体
DK2152290T3 (da)	2007-04-30	2014-08-18	Glaxosmithkline Llc	Fremgangsmåder til indgivelse af anti-il-5-antistoffer
US20090035216A1 (en) *	2007-08-03	2009-02-05	Biomonitor Aps	Method for determining in vivo biopharmaceutical concentration or bioavailability
JP5917143B2 (ja)	2008-03-28	2016-05-11	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅＬＬＣ	処置方法
US8926631B2 (en)	2010-08-06	2015-01-06	MoMelan Technologies, Inc.	Methods for preparing a skin graft without culturing or use of biologics
JP6125436B2 (ja)	2011-02-09	2017-05-10	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅＬＬＣ	凍結乾燥製剤

2009
- 2009-03-27 JP JP2011502090A patent/JP5917143B2/ja active Active
- 2009-03-27 EA EA201071137A patent/EA201071137A1/ru unknown
- 2009-03-27 MX MX2010010667A patent/MX2010010667A/es not_active Application Discontinuation
- 2009-03-27 BR BRPI0910854A patent/BRPI0910854A2/pt not_active IP Right Cessation
- 2009-03-27 CN CN2009801176573A patent/CN102026660A/zh active Pending
- 2009-03-27 AU AU2009228163A patent/AU2009228163B2/en not_active Ceased
- 2009-03-27 US US12/935,038 patent/US9834600B2/en active Active
- 2009-03-27 ES ES09725345.4T patent/ES2441945T3/es active Active
- 2009-03-27 KR KR1020107024046A patent/KR20100134702A/ko not_active Withdrawn
- 2009-03-27 WO PCT/US2009/038509 patent/WO2009120927A2/en not_active Ceased
- 2009-03-27 EP EP09725345.4A patent/EP2274009B1/en not_active Revoked
- 2009-03-27 CA CA2719786A patent/CA2719786A1/en not_active Abandoned
2010
- 2010-09-16 ZA ZA2010/06648A patent/ZA201006648B/en unknown
- 2010-09-21 IL IL208354A patent/IL208354A0/en unknown
2014
- 2014-08-01 JP JP2014158170A patent/JP6069267B2/ja active Active
2016
- 2016-11-01 JP JP2016214438A patent/JP6457463B2/ja active Active
2017
- 2017-11-06 US US15/804,104 patent/US20180057582A1/en not_active Abandoned
2018
- 2018-12-20 JP JP2018238018A patent/JP2019065029A/ja active Pending
2019
- 2019-09-19 US US16/575,903 patent/US11325972B2/en active Active

Also Published As

Publication number	Publication date
US9834600B2 (en)	2017-12-05
EA201071137A1 (ru)	2011-04-29
IL208354A0 (en)	2010-12-30
US11325972B2 (en)	2022-05-10
JP2017048224A (ja)	2017-03-09
JP6069267B2 (ja)	2017-02-01
KR20100134702A (ko)	2010-12-23
ES2441945T3 (es)	2014-02-07
MX2010010667A (es)	2010-11-09
CN102026660A (zh)	2011-04-20
AU2009228163A1 (en)	2009-10-01
JP2019065029A (ja)	2019-04-25
JP2011516422A (ja)	2011-05-26
EP2274009A2 (en)	2011-01-19
US20110020339A1 (en)	2011-01-27
JP6457463B2 (ja)	2019-01-23
WO2009120927A3 (en)	2009-12-30
AU2009228163B2 (en)	2012-08-30
CA2719786A1 (en)	2009-10-01
US20180057582A1 (en)	2018-03-01
EP2274009B1 (en)	2013-11-13
EP2274009A4 (en)	2012-01-25
JP2014240408A (ja)	2014-12-25
JP5917143B2 (ja)	2016-05-11
US20200071395A1 (en)	2020-03-05
WO2009120927A2 (en)	2009-10-01
ZA201006648B (en)	2011-07-27

Legal Events

Date	Code	Title	Description
2015-12-08	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 6A ANUIDADE.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0910854A2 (pt)	2015-10-06	métodos de tratamento
BRPI0910259A2 (pt)	2015-12-01	métodos de tratamento de inflamação
BRPI0917575A2 (pt)	2019-09-24	métodos de tratamento de talassemia
BRPI0919748A2 (pt)	2015-12-08	dipositivo de tratamento
EP2320045A4 (en)	2015-01-14	APPARATUS FOR TREATING EXHAUST GAS
BRPI0906764A2 (pt)	2015-08-18	Processos
LTPA2016041I1 (lt)	2017-01-10	Gydymo būdai panaudojant vaistus - amoniako gaudykles
EP2296593A4 (en)	2015-01-14	MEDICAL HEAD COVER
BRPI0921327A2 (pt)	2015-08-25	Combinação de herbicida-protetor
BRPI0919116A2 (pt)	2015-12-08	método
BRPI0914841A2 (pt)	2015-10-27	aparelho de massagem
FIC20240018I1 (fi)	2024-06-04	Vamoroloni
IT1391555B1 (it)	2012-01-11	Apparato trattamento extracorporeo sangue
BRPI0810206A2 (pt)	2014-10-21	Método de tratar câncer
PT3412687T (pt)	2020-04-03	Métodos de tratamento de dlbcl
PT2361116T (pt)	2019-06-06	Aparelho de irradiação
DK2313489T3 (da)	2015-06-22	Fremstillingsmetode
BRPI0919127A2 (pt)	2015-12-08	métodos para tratamento de água
DK2837348T3 (da)	2020-05-04	Kryokirurgiske fremgangsmåder
BRPI0911625A2 (pt)	2015-08-04	Métodos
DK2244628T3 (da)	2019-09-09	Patientdata-sensorapparat
DK2173831T3 (da)	2012-09-17	Brøndbehandling
BRPI0821652A2 (pt)	2017-04-04	tratamento de biocombustíveis
EP2337157A4 (en)	2014-01-08	CONNECTOR
LT3150178T (lt)	2021-08-10	Stimuliavimo aparatas